XXXX in 26 Doberman pinschers.

@entity2011 @entity353 @entity1087 @entity235 @entity843 @entity409 @entity448 @entity4683 @entity1578 @entity920 @entity3619 @entity221 @entity288
@entity3619 with increased hepatic @entity920 concentration was diagnosed in 25 female and 1 male Doberman Pinscher @entity235 . Common clinical signs included @entity2011 / @entity4683 , @entity353 , @entity448 , @entity1087 , and @entity843 . Increased liver enzyme activities and abnormal liver function test results were the most consistent clinicopathologic changes. The @entity235 were assigned to 3 groups on the basis of clinical course of the disease. Group 1 @entity235 (n = 12) had clinical signs of advanced @entity1578 and died within one week. Group 2 @entity235 (n = 7) had less severe clinical signs of @entity409 and died within one month. Group 3 @entity235 (n = 5) did not have clinical signs of @entity221 or had mild clinical signs of @entity409 and died 1 to 42 months after initial evaluation. One @entity235 could not be reevaluated and another @entity235 was alive 3 months after initial examination. Treatments consisted of supportive care for @entity235 in group 1, and dietary manipulations and @entity288 for @entity235 in groups 2 and 3. The association of increased liver @entity920 concentration and @entity3619 is not known.
